Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT06802978 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-04-23
Summary
The goal of this observational study is to compare blood lipid (fat) levels in participants with chronic kidney disease (CKD) with diabetes and without diabetes and who over 20 years old.
The main question this study aims to answer is:
Does having diabetes make fat problems worse in people with chronic kidney disease (CKD), or is there no connection between them?
Researchers will compare the blood lipid (fat) levels in people with chronic kidney disease (CKD) who have diabetes and those without diabetes to see if having diabetes makes lipid problems worse in CKD patients, or if there is no connection between diabetes and changes in lipid levels.
Participants will need to fast for 10 hours before undergoing this test. This means not eating any food or drinking anything except water.
Samples will be taken and sent to laboratory immediately.
Conditions
- Chronic Kidney Disease Patients
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-01
- Primary Completion
- 2025-05-31
- Completion
- 2025-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
NCT06982079 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
NCT06668753 ·Status: NOT_YET_RECRUITING
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk
NCT01213212 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
NCT03859817 ·Status: UNKNOWN
-
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
NCT05849220 ·Status: UNKNOWN ·Phase: NA
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
Anemia-Related Outcomes in Patients With CKD Treated With Dapagliflozin
NCT06813222 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy
NCT05695573 ·Status: COMPLETED
-
Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
NCT02848508 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT05004428 ·Status: COMPLETED
-
STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT
NCT04616027 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
NCT07173686 ·Status: NOT_YET_RECRUITING
-
Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients
NCT02384902 ·Status: COMPLETED ·Phase: NA
-
May Metformin be Used in Renal Failure?
NCT02710448 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Resistance, Sarcopenia and Plasma BAIBA Levels
NCT04309201 ·Status: COMPLETED
-
Diet and Progression of CKD in Patients With Type 2 Diabetes Mellitus
NCT07169786 ·Status: NOT_YET_RECRUITING
-
Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This
NCT02042768 ·Status: COMPLETED
-
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
NCT06069076 ·Status: NOT_YET_RECRUITING
-
PK and PD of YG1699 in CKD Patients With Diabetes
NCT06648876 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life
NCT06759077 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Differential Effects of Diabetes Therapy on Inflammation
NCT02150707 ·Status: COMPLETED
-
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
NCT03983551 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
NCT05373680 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure
NCT01937858 ·Status: TERMINATED